Her work produced forecasts, code, datasets, decision thresholds, and public health guidance. None became a patent. Her successful EB-1A without patents case showed who used the work, why other modelers trusted her judgment, and how her contributions changed outbreak decisions.
This representative case study presents a completed, anonymized EB-1A matter. Identifying details, employer and institution names, countries, dates, disease events, publication titles, data sources, and certain non-material facts have been withheld or adjusted to protect confidentiality.
Case at a glance
| Profession | Infectious disease epidemiology, mathematical modeling, and outbreak analytics |
| Starting point | A mid-career modeler with doctoral training, about eight years of applied research, legitimate publications, and substantial team work that was poorly attributed to her |
| Main concern | She believed the absence of patents made it difficult to prove original contributions under EB-1A |
| Expert specialization | Short-horizon outbreak forecasting and decision support for state, local, and regional public health agencies |
| Profile building period | Approximately thirteen months |
| Public record at filing | A coherent publication record, about 160 independent citations, an attributed modeling toolkit, completed peer review, invited speaking, independent use, and documented policy or operational reliance |
| Criteria used | Original contributions of major significance, authorship, judging the work of others, and a leading or critical role |
| Evidence deliberately excluded | A speculative patent filing, ordinary memberships, internal manuscript review, unverified download counts, purchased media, and work whose authorship could not be separated from the wider team |
| Result | USCIS approved the EB-1A Form I-140 petition without an RFE; the approval did not by itself grant permanent residence, employment authorization, lawful status, or permission to enter the United States |
The patent column was empty, but the professional record was not
The client first contacted us after comparing her curriculum vitae with profiles of engineers and biomedical inventors. Their petitions discussed patents, licenses, commercial products, and named inventions. Her own record contained none of those items. She had written models, cleaned surveillance data, evaluated forecast performance, and prepared decision briefs during infectious disease events. Much of the work had been released openly or completed under institutional ownership.
We started with the legal standard. USCIS evaluates EB-1A evidence through the criteria listed in its extraordinary-ability policy guidance and then conducts a separate final merits review of the record as a whole. A patent can support a claim when it helps prove an original contribution of major significance. The policy does not make patent ownership a required criterion or a prerequisite for scientists.
The question was therefore not why she lacked a patent. The question was whether her models, analytic methods, datasets, and professional judgment had been used and recognized beyond ordinary employment. That change in focus shaped the entire profile build.
Immigration counsel handled legal eligibility, petition strategy, argument, and filing. Advance My Profile handled the profile audit, contribution reconstruction, authorship plan, dataset attribution, open technical asset, peer-evaluation record, speaking activity, independent-use evidence, recommendation archive, and petition readiness.
Her strongest work was visible in agency decisions, not in an invention database
The client worked in an outbreak-analytics unit that supported public-health teams during seasonal respiratory disease activity and emerging infectious disease events. Her duties included estimating recent transmission, producing short term forecasts, testing scenarios, comparing model performance, and converting uncertain outputs into briefs for non-modeling decision makers.
Inside the unit, she was known as the person who could identify when a forecast was being distorted by reporting delays or a sudden change in testing behavior. She also developed ways to explain uncertainty without reducing a probability range to a single confident number. Public-health teams used her analyses when discussing staffing, surveillance intensity, laboratory planning, and the timing of response measures.
The public record did not tell that story. Most model outputs carried the consortium name. Code repositories listed several contributors without explaining the parts each person designed. Decision briefs were issued under an institutional logo. Her curriculum vitae showed papers and conference presentations, but not the operational decisions that followed from her work.
The audit separated institutional output from her own contribution
We reviewed model notebooks, source control records, forecast submissions, data dictionaries, calibration logs, issue trackers, technical reports, meeting minutes, decision briefs, publication contribution statements, conference files, peer-review records, media requests, grant materials, and letters from modelers and public-health users. Each item was classified by authorship, implementation, independent use, and the result it could support.
The review found three recurring contributions. First, the client had developed a reporting-delay adjustment that improved short horizon estimates when recent case data were incomplete. Second, she had created a decision-threshold method that linked forecast probabilities to defined response options. Third, she had built a performance review process that compared several models and made uncertainty visible to public health users.
A fourth item was removed. A former adviser had suggested filing a patent on the forecasting workflow. The underlying code had multiple institutional contributors, parts had already been published, and the intended use was open public health collaboration. We did not turn a doubtful ownership position into a marketing claim.
A broad modeling profile became a defined area of professional authority
At intake, the client described herself as an epidemiologist and data scientist. Both descriptions were accurate, but they covered too much. The completed profile identified her as an infectious-disease modeler specializing in short-horizon outbreak forecasting and public-health decision support.
The specialty reflected current practice. CDC’s Center for Forecasting and Outbreak Analytics develops modeling, forecasting, and analytic tools to support outbreak response. CDC’s overview of infectious-disease modeling for decision-making also discusses model appraisal, validation, evaluation, and the use of models in public-health decisions. These sources established the professional setting. They did not prove that this client had made a contribution.
The narrow identity connected her prior projects, new publications, public toolkit, speaking activity, judging record, independent letters, and continued work. It also kept the case away from unsupported claims about artificial intelligence, clinical diagnosis, vaccine development, or every branch of epidemiology.
Contribution 1: Correcting the recent past before forecasting the near future
Public-health surveillance data often arrive with delays. Recent counts can appear artificially low because reports are still being entered, laboratory results are incomplete, or weekend and holiday patterns have changed. The client designed a reporting delay adjustment that estimated the likely final value of the most recent observations before the short-horizon forecast was generated.
Her method used historical delay distributions, jurisdiction-specific reporting patterns, and a stability check that prevented the adjustment from overreacting when the reporting process itself changed. She also created an alert that told analysts when the delay pattern no longer resembled the period used to fit the model.
The evidence file contained dated code commits, model specifications, validation reports, comparison runs, forecast submissions, and statements from users who observed the change. During retrospective testing, forecasts built after the adjustment produced lower short-horizon error in the selected jurisdictions than the earlier pipeline. The petition reported the tested result and the conditions under which it applied. It did not claim universal accuracy.
Contribution 2: Turning probabilities into transparent response thresholds
The second contribution began with a communication problem. Decision makers received probability distributions and scenario ranges, but different teams interpreted the same output differently. A thirty percent chance of rapid growth could lead one group to increase surveillance while another waited for certainty.
The client developed a decision threshold framework that linked forecast ranges with pre-defined actions, the cost of acting too early, the cost of acting too late, and the quality of the incoming data. The framework did not allow the model to make policy. It made the assumptions behind each possible response visible and gave public health officials a consistent basis for discussion.
Meeting records, threshold tables, briefing templates, and later use by two public health teams showed how the method moved from analysis to practice. One team adapted the framework for respiratory-disease staffing discussions. Another used it to decide when to increase targeted sampling. The case described these uses without claiming that the client controlled the agencies’ final decisions.
Contribution 3: Comparing models without hiding uncertainty
The third contribution concerned model comparison. The consortium produced outputs from several approaches. A single average score could conceal poor performance during turning points or in jurisdictions with sparse data. The client designed a review system that separated calibration, sharpness, coverage, directional accuracy, and performance during growth, decline, and reporting disruption.
She paired the performance measures with a plain-language uncertainty record. Each forecast release stated the main data limitations, recent changes in reporting, and the conditions that would cause the result to be revised. This made it easier for non-technical users to understand why two models could disagree and why a forecast range might widen.
The system was later used in a multi-institution modeling exercise and in training for public-health analysts. Independent users confirmed that the review format helped them compare models without treating one ranking as proof that a model would perform best in every outbreak.
The contributions were organized into an open decision-support toolkit
After the evidence files were complete, the client organized the reusable parts of her work into the Outbreak Forecast Decision Support Toolkit. The toolkit did not contain confidential surveillance data or agency deliberations. It used synthetic examples and documented code so that other teams could test the methods.
| Toolkit component | Completed content and professional use |
| Reporting-delay module | Estimated incomplete recent observations and flagged changes in the reporting process that could make the adjustment unreliable |
| Forecast evaluation notebook | Compared calibration, interval coverage, directional accuracy, and performance across different epidemic phases |
| Decision-threshold worksheet | Recorded forecast probability, data quality, consequences of early or late action, selected response, and the reason for the decision |
| Uncertainty brief template | Translated assumptions, limitations, revision triggers, and alternative scenarios into language used in public-health meetings |
| Synthetic training dataset | Allowed analysts to practice nowcasting, forecast review, and threshold selection without disclosing real patient or jurisdiction data |
| Implementation guide | Explained how to adapt the toolkit, preserve version history, document local assumptions, and separate model advice from policy authority |
The toolkit was released through a repository that recorded the client’s authorship, version history, documentation, and institutional permissions. A digital object identifier was assigned to the release. This gave other professionals a stable asset to use and cite without claiming patent protection.
Independent use replaced the missing patent as evidence of significance
A patent can show that an idea was formalized, but a patent alone does not prove that a contribution changed the field. In this case, significance was shown through use. A university modeling group used the evaluation notebook in a graduate workshop. A regional public health analytics team adapted the threshold worksheet. A nonprofit disease-surveillance program used the uncertainty brief during a training exercise.
For each use, the evidence archive preserved the request, version supplied, meeting or course material, feedback, and confirmation of what was adopted. Repository stars and raw download counts were not used because they could not establish who had downloaded the material or whether it had been applied.
The petition also linked citations to substance. Independent papers cited the client’s work for reporting delay adjustment, forecast evaluation, or decision communication. The record explained how those citations related to the claimed contributions instead of presenting one total number without context.
The authorship plan filled gaps in attribution rather than chasing a paper count
The client already had legitimate publications, but several were broad consortium papers. We mapped each publication to her actual role and identified subjects she could write about as a first author without disclosing restricted data.
She completed two new first-author papers. The first described validation of reporting-delay adjustments across different data conditions. The second examined how public-health teams could select action thresholds when forecasts were uncertain and response costs were unequal. She also published a technical guide explaining the model comparison and uncertainty framework used in the toolkit.
One manuscript was rejected because the journal wanted a larger prospective evaluation. The client revised the article, narrowed the claim, added a limitations section, and submitted it to a methods journal that accepted applied outbreak analytics. The rejection and revision remained part of the internal evidence archive; the website case does not present publication as an automatic process.
At filing, her record contained a coherent body of work and about 160 independent citations. The petition did not argue that the citation count alone established extraordinary ability. It showed what the cited work contributed and how later users applied it.
Peer evaluation developed in a defensible sequence
Before the profile build, the client had commented on drafts written by colleagues and checked code inside her unit. Those tasks were routine collaboration. They were not presented as judging the work of others.
After her first-author work and toolkit became public, she completed manuscript reviews for epidemiology and infectious-disease modeling journals. She later assessed abstracts for a modeling conference and evaluated submissions to an outbreak-analytics challenge. Invitations, reviewer guidance, completed assignments, editorial confirmations, and event records were retained.
A request to review a machine learning paper outside infectious-disease modeling was declined. Another invitation arrived after the petition evidence cutoff and was not added. The judging record remained close to her actual specialty.
Invited speaking followed completed work
The client first delivered a technical seminar on reporting delays and nowcasting. She later presented the decision-threshold framework to a public-health analytics network and joined an invited panel on communicating model uncertainty during outbreaks. The presentations used the same methods documented in her papers and toolkit.
The work also fit the training needs described by CDC’s Insight Net training program, which provides practice tools for people learning disease modeling and forecasting. That context explained why practical training assets matter. The petition still relied on the client’s own invitations, materials, audience records, and independent use.
Internal project updates and routine employer presentations remained implementation evidence. They were not described as external acclaim.
Independent coverage focused on the work, not a purchased biography
A professional public-health publication interviewed the client after an editor reviewed her toolkit and conference presentation. The resulting article discussed the problem of converting probabilistic forecasts into action thresholds and described her role in developing the framework. A separate public-health podcast invited her to explain reporting delays and forecast revision.
The petition used the article as evidence of external attention and included the podcast as supporting context. The case did not rely on a sponsored profile, a press release written by the client, or an article that merely repeated her curriculum vitae. Published-material criterion was not claimed because the legal team chose to rely on four better-documented criteria.
The critical-role record showed why the institution relied on her
The client’s employer was a recognized public health research institution that contributed analyses during infectious-disease responses. Evidence of institutional distinction included funded programs, multi-agency collaborations, peer-reviewed output, and documented use of the unit’s analyses.
Her own role was supported by more than a title. She was assigned to review forecast validity before release, led the reporting delay workstream, drafted uncertainty sections for decision briefs, and was asked to explain model disagreement during meetings with public-health users. Source records showed when her assessment changed an output, delayed a release pending data checks, or led to a revised interpretation.
The petition did not claim that every consortium forecast belonged to her. It identified the workstreams she led, the decisions she made, and the reason those decisions mattered to the organization’s delivery.
The EB-1A filing used four criteria and a separate final merits record
| EB-1A issue | Evidence used in the completed petition |
| Original contributions of major significance | Reporting delay adjustment, decision threshold framework, model comparison system, independent use, citations tied to substance, agency reliance, and expert confirmation |
| Authorship | Legitimate peer-reviewed papers and a technical guide focused on outbreak forecasting, evaluation, and decision support |
| Judging the work of others | Completed journal reviews, conference abstract assessment, and evaluation of outbreak-analytics challenge submissions |
| Leading or critical role | Responsibility for forecast validation, reporting-delay analysis, uncertainty briefs, and technical interpretation within a distinguished outbreak-analytics institution |
| Final merits | Recognition over time, use outside the employer, continuing requests for her judgment, one defined specialty, and a record showing that other professionals relied on her work |
| Patent issue | No patent criterion was claimed; the filing explained significance through implementation, attribution, independent use, citations, evaluation, and professional reliance |
| Evidence architecture | A source linked index connected each claim to authorship records, code history, validation results, dates, users, limitations, and third party confirmation |
The final merits section did not repeat the criterion summaries. It traced how the client moved from internal technical work to first-author publication, external use, peer evaluation, invited explanation, independent coverage, and continuing work in the same specialty. The absence of patents required no apology because patents were never the measure of her professional field position.
Several attractive but weak claims were left out
- The case did not file a patent merely to place the word patent in the evidence index.
- Open professional memberships and conference attendance were treated as background, not extraordinary-ability criteria.
- Internal code review and comments on colleagues’ drafts were not called judging the work of others.
- Repository stars, page views, and unverified downloads were not presented as proof of adoption.
- Consortium outputs were not attributed solely to the client when the source record showed shared authorship.
- The toolkit was not called a national standard, a commercial product, or a universally adopted platform.
- The petition did not claim that a forecast prevented a specific number of infections, hospitalizations, or deaths.
- A sponsored media package and a pay-to-enter award were declined.
- Restricted surveillance data, agency deliberations, private health information, and identifiable jurisdictions were not disclosed.
- The case did not claim expertise in clinical medicine, vaccine development, laboratory diagnostics, or unrelated branches of artificial intelligence.
The petition was filed when the evidence showed one continuing body of work
We did not wait for a patent because none was needed, and we did not file as soon as three criteria could be listed. The petition was submitted after the contribution files were complete, the new first-author work was published, the toolkit had been used by independent organizations, peer-review assignments were finished, speaking records were documented, and the critical-role archive was source-linked.
The future-work statement remained in the same field. It described continued development of outbreak forecasts, evaluation tools, training assets, and decision-support methods for public-health users. It did not introduce an unrelated startup or a new occupation to make the case appear more ambitious.
USCIS approved the Form I-140 petition without issuing an RFE. The approval confirmed the immigrant petition. It did not itself grant a green card, employment authorization, travel permission, or lawful immigration status. Any later immigrant-visa or adjustment-of-status step remained subject to visa availability, admissibility, and the applicable procedure.
How the profile moved from employed modeler to recognized outbreak forecasting specialist
- A broad epidemiology and data science profile became a defensible specialty in short horizon outbreak forecasting and public health decision support.
- Team model outputs became three contribution files showing the client’s own method, code history, validation, limits, and downstream use.
- Institutional code and reports gained clear authorship through repository records, contributor statements, version history, and a stable toolkit release.
- A mixed publication list became a coherent first author body of work tied to reporting delays, forecast evaluation, uncertainty, and decision thresholds.
- A synthetic dataset and open toolkit gave other organizations materials they could test, teach, adapt, and cite without exposing protected data.
- Routine internal review developed into completed journal, conference, and modeling challenge evaluation.
- Project briefings developed into invited technical seminars, network presentations, and public explanation of the same completed work.
- Independent users and public health professionals confirmed reliance on the methods rather than offering general praise.
- Critical role evidence connected her judgment with forecast release, data-quality checks, interpretation, and institutional delivery.
- The final petition presented sustained recognition and field position without inventing a patent or borrowing achievements from the wider consortium.
What this case teaches scientists who do not have patents
Patents are one possible form of evidence. They are not a universal measure of scientific contribution and are not required for EB-1A. Some fields produce devices and proprietary inventions. Others produce methods, code, datasets, standards, clinical protocols, public tools, or policy systems. The evidence strategy should follow the profession.
A scientist without patents still needs a demanding record. The absence of patents cannot be replaced with vague claims about importance. The case must show what the person created, what was attributable to that person, how the work was tested, who used it, and why independent professionals sought the person’s judgment.
Profile building did not turn this modeler into an inventor. It made her real work legible. Contribution recovery, ethical authorship, dataset attribution, public technical assets, peer evaluation, invited education, independent use evidence, and source-linked documentation gave the petition a record suited to outbreak analytics.
The work also advanced her career outside immigration. She finished with a clear specialist identity, stronger authorship, an open toolkit, external users, completed judging, selected speaking, professional coverage, and a better archive of the decisions she had made during outbreak work.
Advance My Profile develops profession-specific records through profile audits, contribution recovery, ethical profile building, professional profile advancement, expert positioning, independent-use evidence, peer evaluation, industry recognition, and petition readiness. Start with a professional profile evaluation at AdvanceMyProfile.com.